About the Product

Description


Citiflip 250 Injection contains Citicoline, a neuroprotective agent widely used for its role in enhancing brain function and aiding in neurological recovery. Citicoline is an essential intermediary in the synthesis of phosphatidylcholine, a key component of cell membranes, and is vital for maintaining the structural integrity of neuronal membranes.

This injection is primarily used in managing neurological conditions such as stroke, traumatic brain injuries, and cognitive disorders. It aids in reducing brain damage by stabilizing cell membranes and decreasing oxidative stress. Additionally, Citicoline promotes the repair of damaged nerve cells, enhances neurotransmitter function, and supports memory and cognitive performance.

Citiflip 250 Injection is particularly beneficial in acute and chronic neurological conditions, helping improve motor function, attention span, and mental clarity. It is suitable for patients undergoing rehabilitation for neurological impairments, offering significant support in recovery and improved quality of life. Administered under medical supervision, Citiflip is a valuable therapeutic option for various central nervous system disorders.

Mild side effects like headache, nausea, dizziness, or gastrointestinal discomfort may occur.

Used for treating neurological conditions, including stroke, traumatic brain injuries, and cognitive decline.

Administer only under the supervision of a healthcare professional. Not recommended for patients with known hypersensitivity to Citicoline.

Store below 25°C in a dry place, protected from light and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Citicoline 250mg Injection in the PCD pharma franchise market?

Citicoline 250mg Injection has strong demand in the neuro and critical care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners looking to expand in the PCD pharma franchise market.

Why should medical distributors include Citicoline 250mg Injection in their product range?

Medical distributors and wholesalers can benefit from the consistent demand for Citicoline 250mg Injection in stroke management, head injury cases, neurological disorders, and ICU care. It strengthens their neuro injectable portfolio.

Does Cafoli Lifecare offer PCD pharma franchise opportunities for Citicoline 250mg Injection?

Yes, Cafoli Lifecare offers PCD pharma franchise opportunities for Citicoline 250mg Injection with monopoly rights, quality packaging, promotional support, competitive pricing, and reliable supply support for distributors and medical agencies.

What benefits do wholesalers get by partnering for Citicoline Injection distribution?

Wholesalers and medical agencies benefit from steady hospital demand in neurology and critical care, good margins, timely availability, and strong product positioning when partnering with Cafoli Lifecare for this formulation.

How can I become a distributor or franchise partner for Citicoline 250mg Injection?

Medical distributors, stockists, wholesalers, and pharma professionals interested in Citicoline 250mg Injection can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, bulk procurement, pricing details, and distribution support services.